Skip to main content

The efficacy-toxicity conundrum: breaking the mold.

Publication ,  Journal Article
Diehl, LF
Published in: Blood
March 5, 2020

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Blood

DOI

EISSN

1528-0020

Publication Date

March 5, 2020

Volume

135

Issue

10

Start / End Page

704 / 706

Location

United States

Related Subject Headings

  • Lymphadenopathy
  • Immunology
  • Humans
  • Hodgkin Disease
  • Fungi
  • Brentuximab Vedotin
  • 3213 Paediatrics
  • 3201 Cardiovascular medicine and haematology
  • 3101 Biochemistry and cell biology
  • 1114 Paediatrics and Reproductive Medicine
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Diehl, L. F. (2020). The efficacy-toxicity conundrum: breaking the mold. Blood, 135(10), 704–706. https://doi.org/10.1182/blood.2019004464
Diehl, Louis F. “The efficacy-toxicity conundrum: breaking the mold.Blood 135, no. 10 (March 5, 2020): 704–6. https://doi.org/10.1182/blood.2019004464.
Diehl LF. The efficacy-toxicity conundrum: breaking the mold. Blood. 2020 Mar 5;135(10):704–6.
Diehl, Louis F. “The efficacy-toxicity conundrum: breaking the mold.Blood, vol. 135, no. 10, Mar. 2020, pp. 704–06. Pubmed, doi:10.1182/blood.2019004464.
Diehl LF. The efficacy-toxicity conundrum: breaking the mold. Blood. 2020 Mar 5;135(10):704–706.

Published In

Blood

DOI

EISSN

1528-0020

Publication Date

March 5, 2020

Volume

135

Issue

10

Start / End Page

704 / 706

Location

United States

Related Subject Headings

  • Lymphadenopathy
  • Immunology
  • Humans
  • Hodgkin Disease
  • Fungi
  • Brentuximab Vedotin
  • 3213 Paediatrics
  • 3201 Cardiovascular medicine and haematology
  • 3101 Biochemistry and cell biology
  • 1114 Paediatrics and Reproductive Medicine